Acadia Pharmaceuticals
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 17 annual filings
Revenue
$1.07B
Net Income
$391.00M
Assets
$1.56B
EPS (diluted)
$2.30
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001193125-26-072519Summary
Acadia Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (347 views/month).[2]
Key Facts
- Country: United States[3]
- Instance of: public company[4]
- Headquarters location: San Diego[5]
- Stock exchange: Nasdaq[6]
- Industry: pharmaceutical industry[7]
- Inception: 1993[8]
- Official website: http://www.acadia-pharm.com/[9]
- Product or material produced: pimavanserin[10]
- Legal form: 8888[11]
- P14750: 51EB-3A81-15E2-DB44-AC9C[12]